Innoviva (INVA) Misses Q2 EPS by 79c

Innoviva (NASDAQ: INVA) reported Q2 EPS of ($0.55), $0.79 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $76.28 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04